| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
GANX
Gain Therapeutics
|
Jul 01, 2026 | BUY |
Strong Buy
+312.3% avg upside
9 analysts
|
$7.00
266.47% Upside
|
· |
|
MBRX
Moleculin Biotech
|
Jul 01, 2026 | BUY |
Strong Buy
+667.0% avg upside
5 analysts
|
$10.00
278.80% Upside
|
· |
|
SCYX
SCYNEXIS
|
Jun 30, 2026 | BUY |
Strong Buy
+189.7% avg upside
10 analysts
|
$32.00
622.43% Upside
|
· |
|
MNOV
Medicinova
|
Jun 30, 2026 | BUY |
Strong Buy
+417.5% avg upside
5 analysts
|
$6.00
319.64% Upside
|
· |
|
INMB
Inmune Bio
|
Jun 23, 2026 | BUY |
Buy
+627.8% avg upside
11 analysts
|
$8.00
370.59% Upside
|
· |
|
ACHV
Achieve Life Sciences
|
Jun 22, 2026 | BUY |
Strong Buy
+142.2% avg upside
13 analysts
|
$10.00
56.23% Upside
|
+28.0% |
|
IMMP
Immutep
|
Jun 17, 2026 | BUY |
Strong Buy
+1181.4% avg upside
7 analysts
|
$1.50
255.87% Upside
|
· |
|
CNTX
Context Therapeutics
|
Jun 16, 2026 | BUY |
Strong Buy
+840.8% avg upside
12 analysts
|
$4.00
511.82% Upside
|
· |
|
ZVRA
Zevra Therapeutics
|
Jun 11, 2026 | BUY |
Strong Buy
+71.0% avg upside
15 analysts
|
$35.00
150.43% Upside
|
-2.8% |
|
ES:ORY
Oryzon Genomics SA
|
Jun 11, 2026 | BUY |
Strong Buy
+248.2% avg upside
2 analysts
|
$8.78
194.32% Upside
|
· |
|
MTVA
MetaVia
|
Jun 11, 2026 | BUY |
Strong Buy
+1920.9% avg upside
13 analysts
|
$8.00
440.51% Upside
|
· |
|
ATHE
Alterity Therapeutics
|
Jun 10, 2026 | BUY |
Strong Buy
+77.2% avg upside
6 analysts
|
$12.00
123.90% Upside
|
· |
|
MDCX
Medicus Pharma Ltd
|
Jun 03, 2026 | BUY |
Strong Buy
+3383.1% avg upside
4 analysts
|
$2.00
380.52% Upside
|
· |
|
RZLT
Rezolute
|
Jun 03, 2026 | BUY |
Strong Buy
+116.7% avg upside
13 analysts
|
$14.00
185.17% Upside
|
· |
|
ATOS
Atossa Therapeutics
|
Jun 02, 2026 | BUY |
Strong Buy
+819.8% avg upside
6 analysts
|
$20.00
843.35% Upside
|
-7.8% |
|
AIM
AIM ImmunoTech
|
Jun 02, 2026 | BUY |
Buy
+1566.6% avg upside
5 analysts
|
$1.50
435.70% Upside
|
· |
|
BNGO
BioNano Genomics
|
May 28, 2026 | BUY |
Strong Buy
+723.0% avg upside
9 analysts
|
$4.00
247.86% Upside
|
+0.8% |
|
ANVS
Annovis Bio
|
May 28, 2026 | BUY |
Strong Buy
+1178.0% avg upside
7 analysts
|
$8.00
314.42% Upside
|
· |
|
FLNA
Filana Therapeutics
|
May 26, 2026 | BUY |
Buy
+2962.3% avg upside
4 analysts
|
$5.00
306.47% Upside
|
· |
|
FENC
Fennec Pharmaceuticals
|
May 21, 2026 | BUY |
Strong Buy
+50.9% avg upside
9 analysts
|
$15.00
40.26% Upside
|
+7.6% |
|
ONCY
Oncolytics Biotech
|
May 21, 2026 | BUY |
Strong Buy
+703.6% avg upside
12 analysts
|
$3.00
233.76% Upside
|
+7.6% |
|
HIND
Vyome Holdings
|
May 19, 2026 | BUY |
Strong Buy
+1269.6% avg upside
8 analysts
|
$15.00
552.14% Upside
|
+14.4% |
|
OSTX
OS Therapies Incorporated
|
May 19, 2026 | BUY |
Strong Buy
+548.1% avg upside
4 analysts
|
$6.00
217.41% Upside
|
· |
|
DWTX
Dogwood Therapeutics
|
May 19, 2026 | BUY |
Strong Buy
+806.0% avg upside
2 analysts
|
$15.00
906.69% Upside
|
· |
|
PSTV
Plus Therapeutics
|
May 19, 2026 | BUY |
Strong Buy
+707.2% avg upside
11 analysts
|
$12.00
201.59% Upside
|
-7.0% |
|
NTHI
NeOnc Technologies Holdings, Inc.
|
May 18, 2026 | BUY |
Strong Buy
+261.9% avg upside
3 analysts
|
$20.00
352.43% Upside
|
-13.1% |
|
DARE
Daré Bioscience
|
May 18, 2026 | BUY |
Strong Buy
+540.4% avg upside
14 analysts
|
$8.00
282.80% Upside
|
· |
|
CNSP
CNS Pharmaceuticals
|
May 15, 2026 | BUY |
Strong Buy
+452.2% avg upside
5 analysts
|
$10.00
97.18% Upside
|
· |
|
IKT
Inhibikase Therapeutics
|
May 15, 2026 | BUY |
Strong Buy
+202.3% avg upside
8 analysts
|
$8.00
301.93% Upside
|
+0.0% |
|
CMPS
COMPASS Pathways
|
May 15, 2026 | BUY |
Strong Buy
+51.3% avg upside
18 analysts
|
$20.00
46.78% Upside
|
+28.2% |
|
CLRB
Cellectar Biosciences
|
May 15, 2026 | BUY |
Strong Buy
+2939.2% avg upside
7 analysts
|
$10.00
255.87% Upside
|
-19.7% |
|
PMN
ProMIS Neurosciences
|
May 14, 2026 | BUY |
Strong Buy
+391.0% avg upside
7 analysts
|
$35.00
162.17% Upside
|
+2.1% |
|
AZTR
Azitra Inc
|
May 14, 2026 | BUY |
Strong Buy
+561.8% avg upside
1 analyst
|
$1.00
561.79% Upside
|
+6.5% |
|
TLSI
TriSalus Life Sciences
|
May 14, 2026 | BUY |
Strong Buy
+97.2% avg upside
8 analysts
|
$10.00
113.13% Upside
|
+6.3% |
|
SLS
SELLAS Life Sciences Group
|
May 14, 2026 | BUY |
Strong Buy
+366.6% avg upside
15 analysts
|
$10.00
33.31% Downside
|
+101.9% |
|
FEMY
Femasys
|
May 13, 2026 | BUY |
Strong Buy
+1354.8% avg upside
6 analysts
|
$30.00
619.51% Upside
|
-47.0% |
|
APRE
Aprea Therapeutics
|
May 13, 2026 | BUY |
Buy
+2985.9% avg upside
7 analysts
|
$5.00
574.83% Upside
|
+1.5% |
|
BLFS
BioLife Solutions
|
May 12, 2026 | BUY |
Strong Buy
+4.5% avg upside
17 analysts
|
$34.00
20.88% Upside
|
+12.8% |
|
ACXP
Acurx Pharmaceuticals
|
May 12, 2026 | BUY |
Strong Buy
+4446.9% avg upside
4 analysts
|
$10.00
524.93% Upside
|
-14.6% |
|
ADIL
Adial Pharmaceuticals
|
May 12, 2026 | BUY |
Strong Buy
+1652.9% avg upside
6 analysts
|
$8.00
175.82% Upside
|
+68.1% |
|
CHRS
Coherus Biosciences
|
May 12, 2026 | BUY |
Buy
+765.9% avg upside
18 analysts
|
$4.00
175.92% Upside
|
-13.4% |
|
ANIX
Anixa Biosciences
|
May 11, 2026 | BUY |
Strong Buy
+222.6% avg upside
4 analysts
|
$14.00
328.16% Upside
|
· |
|
CAPR
Capricor Therapeutics
|
May 11, 2026 | BUY |
Strong Buy
+114.2% avg upside
12 analysts
|
$50.00
115.36% Upside
|
-4.7% |
|
TOVX
Theriva Biologics
|
May 06, 2026 | BUY |
Strong Buy
+3102.2% avg upside
8 analysts
|
$1.00
298.31% Upside
|
· |
|
PLYX
Polaryx Therapeutics, Inc.
|
Apr 21, 2026 | BUY |
Strong Buy
+255.8% avg upside
1 analyst
|
$10.00
255.82% Upside
|
· |
|
IMNN
Imunon
|
Apr 17, 2026 | BUY |
Strong Buy
+667.9% avg upside
11 analysts
|
$10.00
423.50% Upside
|
-13.6% |
|
MESO
Mesoblast
|
Apr 14, 2026 | BUY |
Strong Buy
+72.3% avg upside
14 analysts
|
$35.00
143.39% Upside
|
+1.2% |
|
AKTX
Akari Therapeutics
|
Apr 08, 2026 | HOLD |
Strong Buy
+1011.2% avg upside
7 analysts
|
— | +277.1% |
|
RVPH
Reviva Pharmaceuticals Holdings
|
Apr 08, 2026 | HOLD |
Strong Buy
+6541.4% avg upside
9 analysts
|
— | -9.5% |
|
ATNM
Actinium Pharmaceuticals
|
Apr 07, 2026 | BUY |
Strong Buy
+670.2% avg upside
11 analysts
|
$5.00
409.66% Upside
|
+0.0% |
|
GNLX
Genelux Corp.
|
Mar 20, 2026 | BUY |
Strong Buy
+506.8% avg upside
7 analysts
|
$12.00
301.35% Upside
|
+21.7% |
|
KAPA
Kairos Pharma, Ltd.
|
Mar 09, 2026 | BUY |
Strong Buy
+2399.3% avg upside
4 analysts
|
$4.00
980.75% Upside
|
-12.5% |
|
ITRMF
Iterum Therapeutics
|
Mar 05, 2026 | HOLD |
Buy
+14262.0% avg upside
5 analysts
|
— | · |
|
HURA
TuHURA Biosciences
|
Mar 03, 2026 | BUY |
Strong Buy
+277.1% avg upside
8 analysts
|
$8.00
227.81% Upside
|
+61.3% |
|
IVF
INVO Fertility
|
Feb 10, 2026 | BUY |
Strong Buy
+465.8% avg upside
3 analysts
|
$20.00
1134.50% Upside
|
-69.1% |
|
QNCX
Quince Therapeutics
|
Feb 02, 2026 | HOLD |
Buy
+20.5% avg upside
16 analysts
|
— | +857.2% |
|
CODX
Co-Diagnostics
|
Jan 23, 2026 | HOLD |
Buy
+560.5% avg upside
5 analysts
|
$5.00
67.14% Upside
|
+185.3% |
|
UNCY
Unicycive Therapeutics
|
Dec 29, 2025 | BUY |
Strong Buy
+828.5% avg upside
10 analysts
|
$30.00
423.56% Upside
|
+36.3% |
|
GNTA
Genenta Science SpA Sponsored ADR
|
Dec 22, 2025 | BUY |
Strong Buy
+810.9% avg upside
3 analysts
|
$7.00
307.07% Upside
|
-52.0% |
|
VTGN
VistaGen Therapeutics
|
Dec 17, 2025 | HOLD |
Hold
+944.6% avg upside
8 analysts
|
— | -30.2% |
|
ARTL
Artelo Biosciences
|
Nov 19, 2025 | HOLD |
Hold
2 analysts
|
— | -75.5% |
|
RNXT
RenovoRx
|
Nov 14, 2025 | BUY |
Strong Buy
+595.5% avg upside
5 analysts
|
$4.00
334.65% Upside
|
+21.2% |
|
INDP
Indaptus Therapeutics
|
Nov 13, 2025 | BUY |
Buy
+2961.1% avg upside
6 analysts
|
$10.00
230.10% Upside
|
-1.4% |
|
CERO
CERo Therapeutics Holdings
|
Nov 07, 2025 | HOLD |
Hold
+762.0% avg upside
2 analysts
|
$0.10
762.03% Upside
|
-77.5% |
|
NEUP
Neuphoria Therapeutics
|
Oct 30, 2025 | BUY |
Strong Buy
+493.9% avg upside
6 analysts
|
$20.00
491.67% Upside
|
+7.5% |
|
ABPO
Abpro Holdings
|
Oct 21, 2025 | HOLD |
Hold
1 analyst
|
— | · |
|
BCLI
Brainstorm Cell Therapeutics
|
Aug 15, 2025 | HOLD |
Hold
+177.7% avg upside
2 analysts
|
— | · |
|
CMMB
Chemomab Therapeutics
|
May 06, 2025 | BUY |
Strong Buy
+1098.2% avg upside
6 analysts
|
$28.00
1133.50% Upside
|
-63.3% |
|
BNBX
BNB Plus
|
Feb 27, 2025 | HOLD |
Strong Buy
+2538.9% avg upside
5 analysts
|
— | -99.3% |
|
KZIA
Kazia Therapeutics
|
Feb 24, 2025 | BUY |
Strong Buy
+87.6% avg upside
7 analysts
|
$15.00
13.23% Upside
|
+50.3% |
|
LIPO
Lipella Pharmaceuticals, Inc.
|
Feb 11, 2025 | BUY |
Strong Buy
+8618.4% avg upside
1 analyst
|
$10.00
8618.43% Upside
|
· |
|
BRTX
BioRestorative Therapies
|
Feb 11, 2025 | BUY |
Strong Buy
+1900.0% avg upside
3 analysts
|
$8.00
1900.07% Upside
|
-82.1% |
|
ATXI
Avenue Therapeutics
|
Nov 15, 2024 | BUY |
Strong Buy
+5801.6% avg upside
4 analysts
|
— | · |
|
MTNB
Matinas BioPharma
|
Oct 31, 2024 | HOLD |
Buy
+2085.8% avg upside
7 analysts
|
— | +122.6% |
|
TAOX
Tao Synergies
|
Jul 11, 2024 | BUY |
Strong Buy
+282.5% avg upside
1 analyst
|
$14.00
282.51% Upside
|
· |
|
BLTE
Belite Bio, Inc. ADR
|
Mar 13, 2024 | BUY |
Strong Buy
+24.6% avg upside
10 analysts
|
$60.00
59.03% Downside
|
+82.8% |
|
DFTX
Definium Therapeutics
|
Mar 11, 2024 | BUY |
Strong Buy
-6.0% avg upside
20 analysts
|
— | -24.0% |
|
LCTX
Lineage Therap
|
Mar 11, 2024 | BUY |
Strong Buy
+296.9% avg upside
16 analysts
|
$5.00
270.31% Upside
|
-58.9% |
|
VNRX
VolitionRX
|
Oct 27, 2023 | BUY |
Strong Buy
+558.8% avg upside
11 analysts
|
$4.00
185.80% Upside
|
-13.6% |
|
BIOCQ
Biocept
|
Sep 21, 2023 | HOLD |
Strong Buy
+42037400.0% avg upside
7 analysts
|
— | · |
|
CFRXQ
ContraFect
|
Sep 18, 2023 | BUY |
Buy
+10969999900.0% avg upside
10 analysts
|
$3.00
299999900.04% Upside
|
· |
|
NCEL
NewcelX
|
Sep 14, 2023 | HOLD |
Buy
+211.6% avg upside
4 analysts
|
— | · |
|
ONCO
Onconetix
|
Sep 13, 2023 | HOLD |
Hold
1 analyst
|
— | -82.2% |
|
PBLA
Panbela Therapeutics
|
Aug 21, 2023 | HOLD |
Buy
+4504404.6% avg upside
3 analysts
|
— | · |
|
ABVC
ABVC BioPharma
|
Aug 21, 2023 | HOLD |
Hold
1 analyst
|
— | -63.4% |
|
GOVX
GeoVax Labs
|
Aug 21, 2023 | BUY |
Strong Buy
+6412.6% avg upside
5 analysts
|
— | +2.9% |
|
MNPR
Monopar Therapeutics Inc
|
Aug 10, 2023 | HOLD |
Strong Buy
+1.6% avg upside
18 analysts
|
— | -41.0% |
|
GLMD
Galmed Pharmaceuticals
|
Jul 24, 2023 | BUY |
Buy
+4184.3% avg upside
13 analysts
|
$4.00
601.23% Upside
|
-75.8% |
|
SCPX
Scorpius Holdings
|
Apr 03, 2023 | HOLD |
Strong Buy
+1664672.7% avg upside
11 analysts
|
— | · |
|
ARDS
Aridis Pharmaceuticals
|
Jan 26, 2023 | HOLD |
Strong Buy
+1324999900.0% avg upside
5 analysts
|
— | -90.6% |
|
BTTC
Black Titan
|
Nov 22, 2022 | HOLD |
Hold
+1115.9% avg upside
2 analysts
|
— | · |
|
PTIX
Protagenic Therapeutics
|
Nov 22, 2022 | HOLD |
Hold
1 analyst
|
— | -63.6% |
|
BCDA
BioCardia
|
Nov 22, 2022 | HOLD |
Strong Buy
+1191.6% avg upside
5 analysts
|
— | -64.7% |
|
PRPO
Precipio
|
Nov 22, 2022 | HOLD |
Buy
-24.8% avg upside
2 analysts
|
— | -53.8% |
|
ERNA
Eterna Therapeutics
|
Nov 22, 2022 | HOLD |
Strong Buy
+1048.4% avg upside
4 analysts
|
— | -68.3% |
|
OMER
Omeros
|
Nov 15, 2022 | HOLD |
Buy
+112.4% avg upside
14 analysts
|
— | -43.9% |
|
ATAI
Atai Beckley N.V.
|
Nov 14, 2022 | BUY |
Strong Buy
+158.2% avg upside
16 analysts
|
$12.00
131.31% Upside
|
-56.1% |
|
ENTX
Entera Bio
|
Nov 11, 2022 | BUY |
Strong Buy
+231.3% avg upside
3 analysts
|
$2.00
20.40% Upside
|
+40.0% |
|
INO
Inovio Pharmaceuticals
|
Nov 09, 2022 | HOLD |
Buy
+730.1% avg upside
19 analysts
|
— | -83.5% |
|
TSE:MDNA
Medicenna Therapeutics Corp
|
Nov 04, 2022 | BUY |
Strong Buy
+1141.6% avg upside
9 analysts
|
$5.68
1337.07% Upside
|
· |
|
SE:MVIR
Medivir AB
|
Aug 19, 2022 | BUY |
Strong Buy
+2229.0% avg upside
2 analysts
|
$29.22
1507.12% Upside
|
· |
|
ENVB
Enveric Biosciences
|
May 26, 2022 | BUY |
Strong Buy
+1003.5% avg upside
2 analysts
|
$25.00
1624.20% Upside
|
-56.8% |
|
HELP
Helus Pharma
|
Feb 11, 2022 | HOLD |
Strong Buy
+614.1% avg upside
12 analysts
|
— | · |
|
GILD
Gilead Sciences
|
Feb 03, 2022 | BUY |
Strong Buy
-10.1% avg upside
66 analysts
|
$84.00
35.91% Downside
|
+35.1% |
|
DMAC
Diamedica Therapeutics
|
Feb 02, 2022 | BUY |
Strong Buy
+97.2% avg upside
12 analysts
|
$6.00
21.24% Downside
|
-48.9% |
|
ADMA
ADMA Biologics
|
Jan 18, 2022 | HOLD |
Strong Buy
+46.0% avg upside
15 analysts
|
— | +145.3% |
|
TSE:APLI
Appili Therapeutics Inc Class A
|
Jan 18, 2022 | HOLD |
Buy
+8294.9% avg upside
3 analysts
|
— | · |
|
NAVBQ
Navidea
|
Jan 18, 2022 | HOLD |
Buy
+2833233.3% avg upside
4 analysts
|
— | · |
|
ONCSQ
OncoSec Medical
|
Oct 21, 2021 | HOLD |
Strong Buy
+4699999900.0% avg upside
9 analysts
|
— | · |
|
PLUR
Pluri
|
Oct 21, 2021 | HOLD |
Strong Buy
+184.3% avg upside
8 analysts
|
— | -75.9% |
|
BLRX
Bioline RX Ltd Sponsored ADR
|
Sep 08, 2021 | HOLD |
Strong Buy
+210.5% avg upside
6 analysts
|
— | -38.8% |
|
CTSO
Cytosorbents
|
Sep 08, 2021 | HOLD |
Strong Buy
+2947.7% avg upside
13 analysts
|
— | -81.0% |
|
ARMP
Armata Pharmaceuticals
|
Sep 08, 2021 | HOLD |
Strong Buy
+137.7% avg upside
4 analysts
|
— | -4.2% |
|
PRFX
PainReform
|
Aug 27, 2021 | BUY |
Buy
+341.2% avg upside
2 analysts
|
$6.00
341.17% Upside
|
· |
|
GRDX
GridAI Technologies
|
Aug 18, 2021 | BUY |
Strong Buy
+360.2% avg upside
7 analysts
|
$30.00
581.73% Upside
|
-97.8% |
|
LKFT
Lakefront Biotherapeutics
|
Aug 09, 2021 | HOLD |
Buy
+246.6% avg upside
24 analysts
|
— | · |
|
CLNN
Clene
|
Aug 05, 2021 | BUY |
Strong Buy
+434.4% avg upside
11 analysts
|
$18.00
195.05% Upside
|
-61.2% |
|
AVTX
Avalo Therapeutics
|
Aug 04, 2021 | BUY |
Strong Buy
+184.9% avg upside
19 analysts
|
$84.00
345.88% Upside
|
-87.4% |
|
VRTX
Vertex Pharmaceuticals
|
Jul 30, 2021 | HOLD |
Strong Buy
-16.7% avg upside
61 analysts
|
— | +39.1% |
|
VKTX
Viking Therapeutics
|
Jul 29, 2021 | BUY |
Strong Buy
+92.1% avg upside
31 analysts
|
$14.00
62.58% Downside
|
-50.3% |
|
ONC
BeOne Medicines
|
Jul 16, 2021 | HOLD |
Strong Buy
+16.5% avg upside
28 analysts
|
— | -45.7% |
|
TSE:APS
Aptose Biosciences
|
Jul 16, 2021 | HOLD |
Strong Buy
+3809.4% avg upside
10 analysts
|
— | · |
|
TRAW
Traws Pharma
|
Jul 16, 2021 | HOLD |
Buy
+4003.1% avg upside
10 analysts
|
— | -75.2% |
|
NMTRQ
9 Meters Biopharma
|
Jun 17, 2021 | BUY |
Buy
+3234374900.0% avg upside
11 analysts
|
$3.00
299999900.02% Upside
|
· |
|
AVNS
Avanos Medical
|
May 13, 2021 | BUY |
Buy
+9.7% avg upside
5 analysts
|
$45.00
80.55% Upside
|
-31.9% |
|
CRDF
Cardiff Oncology
|
May 07, 2021 | BUY |
Strong Buy
+693.5% avg upside
18 analysts
|
$30.00
2262.20% Upside
|
-86.1% |
|
XBIO
Xenetic Biosciences
|
Apr 09, 2021 | HOLD |
Hold
2 analysts
|
— | -50.7% |
|
SNGX
Soligenix
|
Apr 09, 2021 | HOLD |
Buy
+752.7% avg upside
6 analysts
|
— | -51.0% |
|
IDXG
Interpace Diagnostics Group
|
Apr 09, 2021 | HOLD |
Strong Buy
+633.8% avg upside
9 analysts
|
— | · |
|
NL:LKFT
Galapagos
|
Feb 10, 2021 | HOLD |
Sell
+95.1% avg upside
16 analysts
|
— | · |
|
NVNO
enVVeno Medical
|
May 11, 2020 | HOLD |
Hold
2 analysts
|
— | -43.7% |
|
INM
InMed Pharmaceuticals
|
May 11, 2020 | HOLD |
Hold
+1182.0% avg upside
3 analysts
|
— | -40.4% |
|
DXR
Daxor
|
Mar 26, 2020 | BUY |
Strong Buy
+108.8% avg upside
6 analysts
|
$22.00
111.98% Upside
|
-14.9% |
|
ABEO
Abeona Therapeutics
|
Nov 07, 2019 | HOLD |
Strong Buy
+166.7% avg upside
17 analysts
|
— | -62.1% |
|
HEPA
Hepion Pharmaceuticals
|
May 29, 2019 | HOLD |
Strong Buy
+58783.8% avg upside
9 analysts
|
— | · |
|
GB:OXB
Oxford BioMedica
|
May 29, 2019 | HOLD |
Strong Buy
+58.9% avg upside
4 analysts
|
— | · |
|
GNPX
Genprex
|
May 29, 2019 | HOLD |
Strong Buy
+1202.1% avg upside
5 analysts
|
— | +75.3% |
|
ATHXQ
Athersys
|
May 09, 2019 | BUY |
Buy
+2996428471.4% avg upside
8 analysts
|
$8.00
799999900.00% Upside
|
+77.5% |
|
TEVA
Teva Pharmaceutical
|
May 02, 2019 | HOLD |
Buy
-15.2% avg upside
39 analysts
|
— | -31.9% |
|
BYSI
Beyondspring
|
Apr 30, 2019 | HOLD |
Hold
+331.2% avg upside
8 analysts
|
— | -4.3% |
|
TARA
Protara Therapeutics
|
Mar 28, 2019 | HOLD |
Strong Buy
+1178.8% avg upside
21 analysts
|
— | +9.3% |
|
VERU
Veru
|
Feb 13, 2019 | BUY |
Strong Buy
+544.5% avg upside
10 analysts
|
$6.00
96.04% Upside
|
+216.2% |
|
CATX
Perspective Therapeutics
|
Jan 30, 2019 | HOLD |
Strong Buy
+209.1% avg upside
22 analysts
|
— | +100.0% |
|
AVXL
Anavex Life Sciences
|
Jan 30, 2019 | HOLD |
Strong Buy
+772.6% avg upside
9 analysts
|
— | +55.4% |
|
SNOA
Sonoma Pharmaceuticals
|
Jan 30, 2019 | HOLD |
Buy
+1663.0% avg upside
4 analysts
|
— | -20.8% |
|
SINT
Sintx Technologies
|
Oct 03, 2018 | HOLD |
Buy
+325.7% avg upside
8 analysts
|
— | -81.1% |
|
TSE:CSCI
COSCIENS Biopharma
|
Jun 15, 2018 | HOLD |
Strong Buy
+371.9% avg upside
8 analysts
|
— | · |
|
CANF
Can-Fite BioPharma
|
Jun 15, 2018 | HOLD |
Strong Buy
+30.8% avg upside
8 analysts
|
— | -84.9% |
|
MNKD
MannKind
|
Jun 15, 2018 | HOLD |
Buy
+55.7% avg upside
22 analysts
|
— | -39.5% |
|
IPCIQ
IntelliPharmaCeutics International
|
Jun 15, 2018 | HOLD |
Buy
+1649999900.0% avg upside
4 analysts
|
— | · |
|
TSE:BHC
Bausch Health Companies
|
Dec 14, 2017 | BUY |
Buy
+761.0% avg upside
29 analysts
|
— | · |
|
IMUC
ImmunoCellular Therapeutics
|
Nov 22, 2017 | HOLD |
Strong Buy
+2650.0% avg upside
3 analysts
|
— | · |
|
CASIF
CASI Pharmaceuticals
|
Nov 22, 2017 | HOLD |
Strong Buy
+17145.3% avg upside
5 analysts
|
— | · |
|
AIXC
AIxCrypto Holdings
|
Sep 07, 2017 | HOLD |
Strong Buy
+900.0% avg upside
7 analysts
|
— | · |
|
BNTC
Benitec Biopharma
|
Aug 30, 2017 | HOLD |
Strong Buy
+100.5% avg upside
13 analysts
|
— | +36.7% |
|
SDEV
Stablecoin Development Corp
|
Aug 11, 2017 | HOLD |
Buy
-5.1% avg upside
7 analysts
|
— | · |
|
OTLC
Oncotelic Therapeutics
|
Aug 01, 2017 | HOLD |
Strong Buy
+8843.1% avg upside
5 analysts
|
— | · |
|
BPTH
Bio-Path Holdings
|
May 15, 2017 | BUY |
Strong Buy
+17559.5% avg upside
6 analysts
|
$20.00
42453.10% Upside
|
· |
|
EDSA
Edesa Biotech
|
May 10, 2017 | BUY |
Strong Buy
+48.9% avg upside
6 analysts
|
$2.00
73.36% Downside
|
-56.4% |
|
AGEN
Agenus
|
May 08, 2017 | BUY |
Strong Buy
+127.6% avg upside
17 analysts
|
$7.00
100.58% Upside
|
-14.4% |
|
BVNRY
Bavarian Nordic
|
May 05, 2017 | BUY |
Strong Buy
3 analysts
|
— | · |
|
SVRA
Savara
|
Apr 19, 2017 | HOLD |
Strong Buy
+39.6% avg upside
17 analysts
|
— | +4.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.